Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

The sphere of mental health is changing rapidly. For many years, getting psychiatric care meant anxious hours spent in waiting rooms, phone calls to be made and suffering, and expectations that people would look down on you.  Now, there is also a silent shift–that is, another kind of lifestyle for ordinary people. Tele-therapy is how […]

The post The Future of Psychiatry: How Virtual Care Is Breaking Barriers in Mental Health appeared first on Medical News Bulletin.

ORLANDO — Measurable residual disease after induction therapy may serve as an individual-level predictor of survival among patients with acute myeloid leukemia, according to study results presented at ASH Annual Meeting and Exposition.
“AML remains a difficult disease to cure. There have been recent advancements in the past couple of years with new drugs, FLT3 and IDH inhibitors, but it takes a long time for these drugs to be implemented in clinic. That is mainly because a standard clinical trial consists of long follow-up for survival data to mature,” Jesse Tettero, MD, PhD, a postdoctoral

The American Osteopathic Association announced it has filed a lawsuit challenging an American Board of Internal Medicine policy which limits opportunities for internal medicine physicians and residents.
According to the American Osteopathic Association (AOA), the policy blocks qualified residents and fellows from taking the American Board of Internal Medicine’s (ABIM) board certification exams “not because of their competence” but due to their program directors being certified by the American Osteopathic Board of Internal Medicine (AOBIM) instead of the ABIM.
An AOA press release said the

Three women experienced severe illness earlier this year after self-injecting cosmetic botulinum neurotoxin purchased online, according to the CDC’s Morbidity and Mortality Weekly Report.
“This alert from the CDC is critically important because it underscores a growing and dangerous trend in aesthetic medicine: the rise of unregulated, do-it-yourself neuromodulator injections,” Lara Devgan, MD, MPH, FACS, attending plastic surgeon at Lenox Hill Hospital in New York, told Healio. “Botulinum toxin is a prescription medication that requires medical expertise not only for safe administration but

PARIS — Long-term 7-year follow-up data from the Portal extension trial support the port delivery system as an effective strategy to maintain long-term visual outcomes with reduced treatment burden.
At the Euretina congress, Arshad M. Khanani, MD, MA, FASRS, said that the trial was the longest prospective study of patients with wet age-related macular degeneration ever performed.
“We are all aware that patients in the real world lose vision due to under treatment with injections due to treatment burden,” Khanani told Healio. “This data from the port delivery system shows much improved long-term

According to the World Obesity Federation, current trends suggest that 1.13 billion adults will be living with obesity by 2030, an increase of 115% since 2010.
Associated with this increase in obesity is the increase of health risks, including type 2 diabetes, heart disease, kidney disease and osteoarthritis, among others. While weight management can reduce these risks, weight loss maintenance is difficult, with both genetic and environmental factors playing a role.
But the use of GLP-1 receptor agonists for weight loss has increased from 3.7% in 2019 to 16.5% in 2024, according to FAIR Health

ORLANDO — A decade-long investigation of shorter regimens of hypomethylating agents for low-risk myelodysplastic syndrome revealed a 5-day course of azacitidine significantly improved survival compared with 3-day azacitidine and decitabine.
The results, presented at ASH Annual Meeting and Exposition, showed 5-day azacitidine improved EFS and OS with no early deaths or new safety signals.
“A 5-day duration of azacitidine provides the best balance of safety and efficacy in lower-risk myelodysplastic syndrome,” Ian Bouligny, MD, assistant professor in the department of leukemia at The University

BOSTON — In a survey, nearly two-thirds of patients with glaucoma or ocular hypertension were unaware of preservative-free topical treatment options, according to survey results presented here.
Those who were aware of preservative-free treatments but not using them said the main barrier was that their doctors had not recommended or discussed them.
The findings, presented at Academy 2025, came from an online survey conducted by Cecelia Koetting, OD, FAAO, DipABO, assistant professor of ophthalmology at the University of Colorado School of Medicine, and colleagues.
The survey, called the

NEW ORLEANS — Social determinants of health and disease complexity were both key factors influencing gaps in care for congenital heart disease, and a novel AI model may help physicians identify those at highest risk, a speaker reported.
Researchers developed a machine learning model to identify patients with congenital heart disease who may be at risk for experiencing gaps in their lifetime continuous care and presented the results at the American Heart Association Scientific Sessions.
“In the field of congenital heart disease, what we have learned is that these gaps start to happen around

CHICAGO — Vagus nerve-mediated neuroimmune modulation by electrical stimulation using an implantable device was well-tolerated and had durable efficacy through 12-months in adults with rheumatoid arthritis, according to results from the RESET-RA study presented at ACR Convergence 2025.
“Neuroimmune modulation by electrical stimulation of the left cervical vagus nerve represents a novel treatment option for rheumatoid arthritis,” Minna Kohler, MD, RhMSUS, founder and director of the Rheumatology Musculoskeletal Ultrasound Program at Massachusetts General Hospital, director of Onco-Rheumatology